Only praziquantel is available for treating schistosomiasis, a disease affecting >200 million people. Here, the authors identify compounds active against schistosome infections meeting the criteria for lead progression indicated by WHO with better activity against juvenile worms than praziquantel.
- Valentina Z. Petukhova
- Sammy Y. Aboagye
- Pavel A. Petukhov
